DrugBiological
Gosha-jinki-gan clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
TJ Biopharma Co., Ltd. (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gosha-jinki-gan is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)Active, not recruitingPhase 2TJ Biopharma Co., Ltd.NCT04600817Written as TJ107
- Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid TumorsActive, not recruitingPhase 2TJ Biopharma Co., Ltd.NCT05145907Written as TJ107 +Pembrolizumab
- Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid TumorsCompletedPhase 1/2TJ Biopharma Co., Ltd.NCT04001075Written as TJ107